Table 1 Characteristics of the study population at entry

Gender

Male

7 (58.3%)

3 (75.0%)

10 (62.5%)

Female

5 (41.7%)

1 (25.0%)

6 (37.5%)

Skin color

White

16 (100%)

Mean ± SD

66.4 ± 14.1

72 ± 16.3

67.8 ± 14.3

Age (Years)

Median ± QR

70.5 ± 18.0

72.5 ± 31.0

70.5 ± 2.0

Max; Min

(31, 81)

(54, 89)

(31, 89)

Smoker

Yes

6 (50.0%)

1 (25.0%)

7 (43.5%)

No

6 (50.0%)

3 (75.0%)

9 (56.3%)

Alcohol consumption

Yes

1 (8.3%)

1 (25.0%)

2 (12.5%)

No

11 (91.6%)

3 (75%)

14 (87.5%)

No

4 (25%)

Yes

12 (87.5%)

Diseases

Drugs for diseases control

Captopril

1 (20%)

Clortalidone

1 (20%)

Captopril

1 (20%)

AHT

5 (31.2%)

Hydrochlorothiazide

Captopril

1 (20%)

Clortalidone

Enalaprile

1 (20%)

Hydrochlorothiazide

Concurrent diseases (68% of patients)

Cardiac insufficiency

4 (25%)

Dioxin

1 (25%)

Bronchial asthma

2 (12.5%)

Prednisone

1 (50%)

Diabetes

2 (12.5%)

Insulin

1 (50%)

Lung ephysema

2 (12.5%)

Aminophyline

1 (50%)

Allergic rhinitis

1 (6.2%)

Diphenhydramine

1 (100%)

Breast tumor

1 (6.2%)

Duodenal ulcer

1 (6.2%)

Gastric ulcer

1 (6.2%)

Retinosis

1 (6.2%)

Cerebral ischemia

1 (6.2%)